Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,489 | -51,777 | -6,650 | -1,488 | 273 |
| Depreciation Amortization | N/A | 19 | 18 | 17 | N/A |
| Accounts receivable | 831 | -831 | -1,254 | -314 | N/A |
| Other Working Capital | 852 | 3,453 | 1,342 | 200 | 116 |
| Other Operating Activity | 20,791 | 46,871 | 4,686 | 857 | -465 |
| Operating Cash Flow | $-3,015 | $-2,265 | $-1,858 | $-728 | $-76 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -193 |
| PPE Investments | N/A | -2 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 26,119 |
| Investing Cash Flow | $N/A | $-2 | $N/A | $N/A | $25,926 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 620 | 630 | 620 | 229 |
| Common Stock Issued | 14,427 | 2,579 | 1,589 | 177 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -25,998 |
| Other Financing Activity | 0 | 50 | 50 | 50 | 0 |
| Financing Cash Flow | $14,427 | $3,249 | $2,269 | $847 | $-25,769 |
| Beginning Cash Position | 1,859 | 877 | 877 | 877 | 0 |
| End Cash Position | 13,271 | 1,859 | 1,288 | 996 | 81 |
| Net Cash Flow | $11,412 | $982 | $410 | $119 | $81 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,015 | -2,265 | -1,858 | -728 | -76 |
| Capital Expenditure | N/A | -2 | N/A | N/A | N/A |
| Free Cash Flow | -3,015 | -2,267 | -1,858 | -728 | -76 |